|
Jun 20
|
ClearPoint Neuro Congratulates Partner Aspen Neuroscience on Use of the ClearPoint® Navigation System for All Enrolled Patients in ASPIRO Clinical Trial
|
|
Jun 20
|
Parkinson's Disease Clinical Trial Uses Intraoperative MRI to Guide Precision Implantation of Patients' Own Autologous Replacement Neurons
|
|
May 8
|
ClearPoint Neuro Inc (CLPT) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue Growth ...
|
|
May 7
|
ClearPoint Neuro Reports First Quarter 2024 Results
|
|
May 2
|
ClearPoint Neuro to Present Novel Research and Exhibit at the 27th American Society of Gene & Cell Therapy Annual Meeting in Baltimore
|
|
Apr 29
|
ClearPoint Neuro Announces FDA Clearance of Prism Bone Anchor Accessory
|
|
Apr 24
|
ClearPoint Neuro Announces Initiation of Limited Market Release for the SmartFrame OR™ Stereotactic System
|
|
Apr 23
|
ClearPoint Neuro to Announce First Quarter 2024 Results May 7, 2024
|
|
Apr 19
|
Is There Now An Opportunity In ClearPoint Neuro, Inc. (NASDAQ:CLPT)?
|
|
Apr 16
|
ClearPoint Neuro Congratulates its Partner AviadoBio on First Patient Treated in its ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN Mutations
|
|
Mar 19
|
ClearPoint Neuro Congratulates its Partner PTC Therapeutics on Completion of Biologics License Application Submission to FDA for Upstaza™ as a Treatment for AADC Deficiency
|
|
Mar 15
|
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Annual Results: Here's What Analysts Are Forecasting For This Year
|
|
Mar 14
|
ClearPoint Neuro Full Year 2023 Earnings: Beats Expectations
|
|
Mar 12
|
ClearPoint Neuro Inc Reports Robust Revenue Growth in Q4 and Full-Year 2023
|
|
Mar 12
|
ClearPoint Neuro Reports Fourth Quarter and Full-Year 2023 Results
|
|
Mar 11
|
Journal of Neurosurgery Publication Demonstrates Distinct Advantages of ClearPoint Prism® Neuro Laser Therapy System
|
|
Jan 16
|
ClearPoint Neuro Announces FDA Clearance for SmartFrame OR™ Stereotactic System
|
|
Jan 8
|
ClearPoint Neuro Reports Fourth Quarter and Full Year 2023 Preliminary Revenue Results and Guidance for Full Year 2024 Revenue
|
|
Dec 19
|
Those who invested in ClearPoint Neuro (NASDAQ:CLPT) five years ago are up 365%
|
|
Oct 26
|
ClearPoint Neuro to Announce Third Quarter 2023 Results November 9, 2023
|